Adalimumab: indicació avaluada; per al tractament de la uveïtis no infecciosa no anterior en pacients adults
Uveitis is an inflammatory disease that affects the intermediate layer of the eye or uvea (iris, cosmylate and choroid), and that many times it can also affect adjacent structures. The illness attends symptoms of severe intraocular inflammation, pain and vision impairment, and patients are at risk of developing permanent and blind eye damage. It is estimated that the incidence of uveitis is 45 cases per 100,000 inhabitants, and the prevalence oscillates according to the different studies between 70-140 cases per 100,000 inhabitants. Uveits not Infectious (UNI) is the result of an abnormal inflammatory response and accounts for 70% of all cases of uveitis in western countries. Intermediate uveitis, posterior and peanveitis, from now infectious uveitis no previous (UNINA); They are less common than the previous uveitis (1 out of 4 UNI diagnostics), but they are more serious and are more likely to experience loss of vision
Inflammatory diseases; Eyes; Adult patients
Adalimumab: indicació avaluada; per al tractament de la uveïtis no infecciosa no anterior en pacients adults. Barcelona: Servei Català de la Salut; 2017.
Use this identifier for quote and/or link this documenthttp://hdl.handle.net/11351/3654
This item appears in following collections
The following license files are associated with this item: